productinfo.htm

Probion - Probion bifido -

mikrobalans - mikrobalans nonlac

180 tablets, 500 mg E7 cfu/g

Declaration: Active lactic acid bacterial culture containing: Str. thermophilus, L. bulgaricus 200 mg, Inulin (fructooligosaccarides) 196 mg, Dicalciumphoshate 100 mg, Magnesiumstearate 4 mg

Classification: Probion is a transient lactic acid bioculture with metabolic carbohydrate fibres. The culture is activated and multiplied in the gastrointestinal tract. It is excreted in the feces, contributing to a high amount of the total fecal weight. The inulin promotes a healthy microflora i.e. it is bifidogenic.

Indications: Supports and balances the healthy intestinal flora. Helps in cases of digestive problems. Promotes the absorption of nutrients, i.e. amino acids, vitamins, minerals. Detoxifies the intestine, the blood and the liver. Supports the immune system.

Contraindications: People with a history of anafylactic reaction due to milkprotein intake.

Side-effects: First 1-3 weeks there could be a period with changes in defecation habits.

Interaction: Due to the effect of Probion, the intestinal mucosa will be influenced and thereby the quality of absorption. If on continous drug administration consult Your practitioner.

Dosage: 1-3 tablets twice daily. Sensitive individuals may start with1 tablet once a day the first week or two. Probiotic supplementation is transitory in itself and continous use should be considered regular dietary practice.

Toxicity: None. Generally recognized as safe by the swedish health authorities.

Packing: 180 tablets in 100 ml plastic bottles.

To the top of the page


150 tablets, 350 mg E6-7 cfu/g

Declaration: Active lactic acid bacterial culture containing: Str. thermophilus Bifidobacterium animalis L. bulgaricus 21,0 mg, Inulin ( fructooligosaccarides ) 326,5 mg, Magnesiumstearate 2,5 mg

Classification: Probion bifido is transient lactic acid bioculture with metabolic carbohydrate fibres. The culture is activated and multiplied in the gastrointestinal tract. It is excreted in the feces, contributing to a high amount of the total fecal weight. The inulin promotes a healthy microflora i.e. it is bifidogenic.

Indications: Supports and balances the healthy intestinal flora. Helps in cases of digestive problems. Promotes the absorption of nutrients, i.e. amino acids, vitamins, minerals. Detoxifies the intestine, the blood and the liver. Supports the immune system.

Contraindications: People with a history of anafylactic reaction due to milkprotein intake.

Side-effects: First 1-3 weeks there could be a period with changes in defecation habits.

Interaction: Due to the effect of Probion bifido, the intestinal mucosa will be influenced and thereby the quality of absorption. If on continous drug administration consult Your practitioner.

Dosage: 1-3 tablets twice daily. Sensitive individuals may start with1 tablet once a day the first week or two. Probiotic supplementation is transitory in itself and continous use should be considered regular dietary practice.

Toxicity: None. Generally recognized as safe by the swedish health authorities.

Packing : 150 tablets in 75 ml plastic bottles.

To the top of the page


400 g E8-9cfu/g

Declaration: Active lactic acid bacterial culture containing: L. bulgaricus, Str. thermophilus, L. plantarum, Bifidobacterium anim. 120 g, Inulin (fructooligosaccarides) 160 g, Fructose 120 g

Classification: Mikrobalans is a transient lactic acid bioculture with metabolic carbohydrate fibres. The culture is activated and multiplied in the gastrointestinal tract. It is excreted in the feces, contributing to a high amount of the total fecal weight. The inulin promotes a healthy microflora i.e. it is bifidogenic.

Indications: Supports and balances the healthy intestinal flora. Helps in cases of digestive problems. Promotes the absorption of nutrients, i.e. amino acids, vitamins, minerals. Detoxifies the intestine, the blood and the liver. Supports the immune system.

Contraindications: None

Side-effects: First 1-3 weeks there could be a period with changes in defecation habits.

Interaction: Due to the effect of Mikrobalans, the intestinal mucosa will be influenced and thereby the quality of absorption. If on continous drug administration consult Your practitioner.

Dosage: 1-2 doses or 2-4 tsp (5-10 g) once daily. Mix in a glass of water or with cool food. Probiotic supplementation is transitory in itself and continous use should be considered regular dietary practice.

Toxicity: None. Generally recognized as safe by the swedish health authorities.

Packing: 400 g of powder in 500 ml plastic bottles

To the top of the page


300g, E8-9cfu/g

Declaration: Active lactic acid bacterial culture containing: Bifidobacterium animalis 0,4 g, Inulin (fructooligosaccarides) 180 g, Fructose 120 g

Classification: mikrobalans nonlac is a transient lactic acid bioculture with metabolic carbohydrate fibres. The culture is a non-dairy product. The culture is activated and multiplied in the gastrointestinal tract. It is excreted in the feces, contributing to a high amount of the total fecal weight. The inulin promotes a healthy microflora i.e. it is bifidogenic.

Indications: Supports and balances the healthy intestinal flora. Helps in cases of digestive problems. Promotes the absorption of nutrients, i.e. amino acids, vitamins, minerals. Detoxifies the intestine, the blood and the liver. Supports the immune system.

Contraindications: None

Side-effects: First 1-3 weeks there could be a period with changes in defecation habits.

Interaction: Due to the effect of Mikrobalans nonlac, the intestinal mucosa will be influenced and thereby the quality of absorption. If on continous drug administration consult Your practitioner.

Dosage: 1-2 doses or 2-4 tsp (5-10 g) once daily. Mix in a glass of water or with cool food. Probiotic supplementation is transitory in itself and continous use should be considered regular dietary practice.

Toxicity: None. Generally recognized as safe by the swedish health authorities.

Packing: 300 g of powder in 500 ml plastic bottles

To the top of the page

Back to Back to main page